National debts of Aek Pharma
Aek Pharma debt entries in KRZ
Company age:
Age:
6 y. 8 m. 15 d.
Share capital:
Share capital:
800 000 PLN
The latest check (2025-09-27) in KRZ shows that Aek Pharma has 12 KRZ records. These records are distributed s follows: Discontinued enforcement proceedings - 12.
The total company's debt is
-105 421 PLN
Discontinued enforcement proceedings
| Type of Proceedings | Case Number | Registration Date | Discontinuation Date | Status | Total |
|---|---|---|---|---|---|
| umorzone postępowanie egzekucyjne | TW4040022009790 | 2024-04-03 | 2024-05-06 |
completed
|
-11 520,66 PLN |
| umorzone postępowanie egzekucyjne | TW1040021005481 | 2024-04-03 | 2024-05-06 |
completed
|
-803,26 PLN |
| umorzone postępowanie egzekucyjne | TW1040021005479 | 2024-04-03 | 2024-05-06 |
completed
|
-10 216,86 PLN |
| umorzone postępowanie egzekucyjne | 0405-SEE.711.345.2022.11 | 2022-03-21 | 2022-04-12 |
completed
|
-24 994,95 PLN |
| umorzone postępowanie egzekucyjne | TW4040023003778 | 2024-04-03 | 2024-05-06 |
completed
|
-3 506,55 PLN |
| umorzone postępowanie egzekucyjne | TW4040022009789 | 2024-04-03 | 2024-05-06 |
completed
|
-40 639,64 PLN |
| umorzone postępowanie egzekucyjne | TW4040023003779 | 2024-04-03 | 2024-05-06 |
completed
|
-1 240,19 PLN |
| umorzone postępowanie egzekucyjne | TW4040021007346 | 2024-04-03 | 2024-05-06 |
completed
|
-1 537,58 PLN |
| umorzone postępowanie egzekucyjne | TW4040022009791 | 2024-04-03 | 2024-05-06 |
completed
|
-3 655,58 PLN |
| umorzone postępowanie egzekucyjne | 0405-SEE.711.345.2022.11 | 2022-03-21 | 2022-04-12 |
completed
|
-2 644,82 PLN |
| umorzone postępowanie egzekucyjne | TW1040021005480 | 2024-04-03 | 2024-05-06 |
completed
|
-2 812,30 PLN |
| umorzone postępowanie egzekucyjne | TW1040021004542 | 2024-04-03 | 2024-05-06 |
completed
|
-1 848,73 PLN |
We regularly monitor all companies in our database, including Aek Pharma, against the National Register of Debtors (KRZ) to identify any new entries.
Debt in companies can have a significant impact on their financial stability and future development. Companies often use loans or bonds to finance investments, but excessive debt can lead to liquidity problems and limit opportunities for further expansion. High liabilities can also affect the company's ability to pay suppliers and employees on time. Therefore, it is crucial to properly manage debt, negotiate favorable repayment terms, and avoid the risk of excessive debt, which can lead to insolvency or bankruptcy.